Skip to main content

Advertisement

Log in

Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review

  • Case Based Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sparks JA (2019) Rheumatoid arthritis. Ann Intern Med 170(1):ITC1–ITC16

    Article  PubMed  Google Scholar 

  2. Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP (2020) Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment. Neurohospitalist 10(2):88–94

    Article  PubMed  Google Scholar 

  3. Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P (2018) Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res ClinRheumatol 32(4):500–510

    Article  Google Scholar 

  4. Tsuzaki K, Nakamura T, Okumura H, Tachibana N, Hamano T (2017) Rheumatoid meningitis occurring during etanercept treatment. Case Rep Neurol Med. https://doi.org/10.1155/2017/7638539

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ahmed M, Luggen M, Herman JH, Weiss KL, Decourten-Myers G, Quinlan JG, Khanna D (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33(11):2344–2346

    CAS  PubMed  Google Scholar 

  6. Seago S, Stroberg E, Metting A (2016) Rheumatoid meningitis associated with infliximab. Proc (BaylUniv Med Cent) 29(2):204–206

    Google Scholar 

  7. Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB (2013) Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol 28(13):212

    Article  Google Scholar 

  8. Wright WF, Pinto CN, Palisoc K, Baghli S (2019) Viral (aseptic) meningitis: a review. J NeurolSci 398:176–183

    Google Scholar 

  9. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. RheumatolInt 31:1409–1417

    Article  Google Scholar 

  10. Gherghel N, Stan A, Stan H (2018) Pearls & Oy-sters: rheumatoid meningitis occurring during treatment with etanercept. Neurology 91(17):806–808

    Article  PubMed  Google Scholar 

  11. Koopmansch C, D’Haene N, Hastir D, Sadeghi N, Maris C, Salmon I (2016) A 63-year-old woman with a right frontal lesion. Brain Pathol 26(4):555–556

    Article  PubMed  PubMed Central  Google Scholar 

  12. Huys AC, Guerne PA, Horvath J (2012) Rheumatoid meningitis occurring during adalimumab and methotrexate treatment. Joint Bone Spine 79(1):90–92

    Article  PubMed  Google Scholar 

  13. Chou RC, Henson JW, Tian D, Hedley-Whyte ET, Reginato AM (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65(8):1114–1116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Nihat A, Chinthapalli K, Bridges L, Johns P, Sofat N, Moynihan B (2016) Rheumatoid meningitis. PractNeurol 16(4):312–314

    Google Scholar 

  15. Qin Z, Kim J, Valencia D, Hamoodi L, Neltner J, Sizemore T, Lightfoot R Jr (2020) Rheumatoid meningitis: a case report and review of the literature. NeurolClinPract 10(1):73–83

    Google Scholar 

  16. Marotte H, Charrin JE, Miossec P (2001) Infliximab-induced aseptic meningitis. Lancet 358(9295):1784

    Article  CAS  PubMed  Google Scholar 

  17. Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. ClinExpRheumato 32(5):732–734 (Epub 2014 Sep 8)

    Google Scholar 

  18. Trabelsi M, Romand X, Gilson M, Vaillant M, Guerne PA, Hayem G, Bertolini E, Baillet A, Gaudin P (2020) Rheumatoid meningitis a rare extra-articular manifestation of rheumatoid arthritis: report of 6 cases and literature review. J Clin Med 9(6):1625

    Article  PubMed Central  Google Scholar 

  19. Jazeron A, Lallier JC, Rihn B, Thiercelin MC (2010) Aseptic meningitis possibly induced by adalimumab. Joint Bone Spine 77(6):618–619

    Article  PubMed  Google Scholar 

  20. Booker MJ, Flint J, Saravana S (2008) Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report. Cases J 1(1):364

    Article  PubMed  PubMed Central  Google Scholar 

  21. Figueroa Rodriguez F, Minkyung K, Jinna S, Farshad S, Davila F (2018) Rheumatoid meningoencephalitis: a feared condition in the era of tnf blockers. Case Rep Rheumatol 2018:4610260

    PubMed  PubMed Central  Google Scholar 

  22. Matsushima M, Yaguchi H, Niino M, Akimoto-Tsuji S, Yabe I, Onishi K, Sasaki H (2010) MRI and pathological findings of rheumatoid meningitis. J ClinNeurosci 17(1):129–132

    Google Scholar 

  23. Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68(13):1079–1080

    Article  PubMed  Google Scholar 

  24. Tortorella C, Prosperini L, Sebastiani G, Gasperini C (2020) Unilateral meningitis: unusual central nervous system involvement in rheumatoid arthritis. PractNeurol. https://doi.org/10.1136/practneurol-2020-002685

    Article  Google Scholar 

  25. Inoue C, Hagiya H, Nishimura Y, Sui O (2020) Rheumatoid meningoencephalitis. Intern Med 59(24):3255–3256

    Article  PubMed  PubMed Central  Google Scholar 

  26. Schmid L, Müller M, Treumann T, Arnold W, Möller B, Aeberli D, Villiger PM (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60(6):1632–1634

    Article  CAS  PubMed  Google Scholar 

  27. McKenna MC, Vaughan D, Bermingham N, Cronin S (2019) Rheumatoid arthritis presenting as rheumatoid meningitis. BMJ Case Rep 12(1):bcr-2018-226649

    Article  PubMed  PubMed Central  Google Scholar 

  28. Finkelshtein V, Lampl Y, Lorberboym M, Kanner A, Ben-Ami Raichman D, Dabby R, Tanay A (2018) Self-limited rheumatoid meningitis as a presenting symptom of rheumatoid arthritis. Isr Med Assoc J 20(4):262–264

    PubMed  Google Scholar 

  29. Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. OculImmunolInflamm 18(6):475–481

    CAS  Google Scholar 

  30. Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, Mariette X; Club Rhumatismes et Inflammation Section of the SFR (2013) Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 52(5):868–874

    Article  Google Scholar 

  31. Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A (2020) association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurol 77(8):937–946

    Article  PubMed  Google Scholar 

  32. Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. FundamClinPharmacol 32(3):252–260

    CAS  Google Scholar 

  33. Shapiro WR, Young DF (1984) Neurological complications of antineoplastic therapy. ActaNeurolScandSuppl 100:125–132

    CAS  Google Scholar 

  34. Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41(11):1906–1911

    Article  CAS  PubMed  Google Scholar 

  35. Vieira WP, Nobre CA, Filho JD, Vieira RM, Callado MR (2009) Meningitetuberculosaduranteterapia com infliximab (Tuberculosis meningitis during infliximab therapy). ActaRheumatol Port 34(4):681–682

    Google Scholar 

  36. Parsons AM, Zuniga LA, Hoxworth JM, Lyons M, Aslam F, Goodman BP (2018) Rheumatoid meningitis: a case review. Neurologist 23(3):83–85

    Article  PubMed  Google Scholar 

  37. Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-α blockers. CurrNeurolNeurosci Rep 17(4):36

    Google Scholar 

  38. Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44(9):1977–1983

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding.

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: RY, DUC, and CK; analysis and interpretation of data: RY, DUC, DA, SS and CK; drafting of the manuscript: RY, DUC, DA, SS and CK, critically revision of the manuscript for important intellectual content: RY, DUC, and CK; final approval of the version to be published: RY, DUC, DA, SS and CK.

Corresponding author

Correspondence to Reşit Yıldırım.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were by the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from our patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yıldırım, R., Cansu, D.Ü., Arık, D. et al. Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review. Rheumatol Int 41, 1845–1853 (2021). https://doi.org/10.1007/s00296-021-04822-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04822-6

Keywords

Navigation